Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia.
Crawford J, Calle RA, Collins SM, Weng Y, Lubaczewski SL, Buckeridge C, Wang EQ, Harrington MA, Tarachandani A, Rossulek MI, Revkin JH. Crawford J, et al. Among authors: revkin jh. Clin Cancer Res. 2024 Feb 1;30(3):489-497. doi: 10.1158/1078-0432.CCR-23-1631. Clin Cancer Res. 2024. PMID: 37982848 Free PMC article. Clinical Trial.
Mortality burden of pre-treatment weight loss in patients with non-small-cell lung cancer: A systematic literature review and meta-analysis.
Bonomi PD, Crawford J, Dunne RF, Roeland EJ, Smoyer KE, Siddiqui MK, McRae TD, Rossulek MI, Revkin JH, Tarasenko LC. Bonomi PD, et al. Among authors: revkin jh. J Cachexia Sarcopenia Muscle. 2024 Apr 22. doi: 10.1002/jcsm.13477. Online ahead of print. J Cachexia Sarcopenia Muscle. 2024. PMID: 38650388 Free article. Review.
ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitor.
Singer DE, Atlas SJ, Go AS, Lopes RD, Lubitz SA, McManus DD, Revkin JH, Mills D, Crosson LA, Lenane JC, Aronson RS. Singer DE, et al. Among authors: revkin jh. Am Heart J. 2022 Jul;249:76-85. doi: 10.1016/j.ahj.2022.04.005. Epub 2022 Apr 25. Am Heart J. 2022. PMID: 35472303 Clinical Trial.
Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week.
Van Spall HGC, Lala A, Deering TF, Casadei B, Zannad F, Kaul P, Mehran R, Pearson GD, Shah MR, Gulati M, Grines C, Volgman AS, Revkin JH, Piña I, Lam CSP, Hochman JS, Simon T, Walsh MN, Bozkurt B; Global CardioVascular Clinical Trialists (CVCT) Forum and Women As One Scientific Expert Panel. Van Spall HGC, et al. Among authors: revkin jh. J Am Coll Cardiol. 2021 Jun 15;77(23):2960-2972. doi: 10.1016/j.jacc.2021.04.038. J Am Coll Cardiol. 2021. PMID: 34112322 Free article. Review.
Defining the path ahead for NOAC use in the pediatric population: A Cardiac Safety Research Consortium Think Tank.
Seltzer JH, Farrell A, Goldenberg N, Hornik C, Keene D, Krucoff MW, Lipardi C, Massicotte P, Mentzer D, Monagle P, Thornburg C, Revkin JH, Walker S, Gajjar D. Seltzer JH, et al. Among authors: revkin jh. Am Heart J. 2020 Jun;224:138-147. doi: 10.1016/j.ahj.2020.02.012. Epub 2020 Feb 28. Am Heart J. 2020. PMID: 32388153 Free article. Review. No abstract available.
Effects of torcetrapib in patients at high risk for coronary events.
Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B; ILLUMINATE Investigators. Barter PJ, et al. Among authors: revkin jh. N Engl J Med. 2007 Nov 22;357(21):2109-22. doi: 10.1056/NEJMoa0706628. Epub 2007 Nov 5. N Engl J Med. 2007. PMID: 17984165 Free article. Clinical Trial.
25 results